Volume 5, Number 5—October 1999
Research
The Economic Impact of Pandemic Influenza in the United States: Priorities for Intervention
Table 7
Mean (s.d.) insurance premium ($ millions) |
||||||||
---|---|---|---|---|---|---|---|---|
Low vaccine effectivenessb
x 40% compliance
Probability of pandemic |
High vaccine effectivenessb
x 60% compliance
Probability of pandemic |
|||||||
Gross attack rate | Cost of vaccination per vaccinee ($) | |||||||
1 in 30 years | 1 in 60 years | 1 in 100 years | 1 in 30 years | 1 in 60 years | 1 in 100 years | |||
15% | 21 | 306 (122) | 153 (61) | 92 (37) | 872 (341) | 435 (170) | 262 (103) | |
62 | 162 (122) | 81 (61) | 48 (37) | 654 (341) | 326 (170) | 196 (103) | ||
25% | 21 | 561 (204) | 280 (102) | 168 (61) | 1,528 (569) | 762 (284) | 459 (171) | |
62 | 416 (204) | 207 (102) | 125 (61) | 1,311 (569) | 653 (284) | 394 (171) | ||
35% | 21 | 815 (286) | 406 (142) | 245 (86) | 2,184 (796) | 1,089 (397) | 656 (239) | |
62 | 670 (286) | 334 (142) | 201 (86) | 1,967 (796) | 980 (397) | 591 (239) |
aDefined here as the amount of money to be spent each year to plan, prepare, and practice to ensure that such mass vaccinations can take place if needed. See text for description of calculating premiums. The mathematically optimal allocation of such funds for each activity requires a separate set of calculations.
bLow and high levels of vaccine effectiveness are defined in the Appendix.
Page created: December 15, 2010
Page updated: December 15, 2010
Page reviewed: December 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.